TY - JOUR
T1 - Going viral
T2 - Next-generation sequencing applied to phage populations in the human gut
AU - Reyes, Alejandro
AU - Semenkovich, Nicholas P.
AU - Whiteson, Katrine
AU - Rohwer, Forest
AU - Gordon, Jeffrey I.
N1 - Funding Information:
Work from the authors’ laboratories that is described in this Review was supported by the US National Institutes of Health (NIH) (grants DK78669, DK30292 and DK70977 to J.I.G. and grant GM095384 to F.L.R.) and by the Crohn’s and Colitis Foundation of America. A.R. is the recipient of an International Fulbright Science and Technology Award. N.P.S. is a member of the Washington University Medical Scientist Training Program (MSTP), which is funded by NIH grant GM007200. Owing to space limitations, the authors were not able to cite many wonderful studies that are relevant to the topics covered.
PY - 2012/9
Y1 - 2012/9
N2 - Over the past decade, researchers have begun to characterize viral diversity using metagenomic methods. These studies have shown that viruses, the majority of which infect bacteria, are probably the most genetically diverse components of the biosphere. Here, we briefly review the incipient rise of a phage biology renaissance, which has been catalysed by advances in next-generation sequencing. We explore how work characterizing phage diversity and lifestyles in the human gut is changing our view of ourselves as supra-organisms. Finally, we discuss how a renewed appreciation of phage dynamics may yield new applications for phage therapies designed to manipulate the structure and functions of our gut microbiomes.
AB - Over the past decade, researchers have begun to characterize viral diversity using metagenomic methods. These studies have shown that viruses, the majority of which infect bacteria, are probably the most genetically diverse components of the biosphere. Here, we briefly review the incipient rise of a phage biology renaissance, which has been catalysed by advances in next-generation sequencing. We explore how work characterizing phage diversity and lifestyles in the human gut is changing our view of ourselves as supra-organisms. Finally, we discuss how a renewed appreciation of phage dynamics may yield new applications for phage therapies designed to manipulate the structure and functions of our gut microbiomes.
UR - http://www.scopus.com/inward/record.url?scp=84865169911&partnerID=8YFLogxK
U2 - 10.1038/nrmicro2853
DO - 10.1038/nrmicro2853
M3 - Review article
C2 - 22864264
AN - SCOPUS:84865169911
SN - 1740-1526
VL - 10
SP - 607
EP - 617
JO - Nature Reviews Microbiology
JF - Nature Reviews Microbiology
IS - 9
ER -